MoneyThe story, in brief
Alphabet spinoff Isomorphic Labs reportedly raising funding at up to $50B valuation
$40B–$50B. That's the valuation Isomorphic Labs—Alphabet's drug-discovery spinoff—is eyeing in a new funding round.
The KeyNews take
Why it matters
Isomorphic Labs, Alphabet's AI-for-drug-discovery spinoff, is raising at a $40–$50B valuation. The round size is undisclosed, but the valuation signals how aggressively capital is chasing AI applications in biotech and life sciences—a category attracting structural venture interest alongside frontier model labs.
The key facts
5 to knowIsomorphic Labs valuation range: $40B–$50B
Company: Alphabet spinoff, focused on drug discovery acceleration
Round size: not specified in Bloomberg report
Status: funding discussions reported; no deal close date disclosed
Context: life-sciences AI application funding trend
Go to the source
SiliconAnglesiliconangle.com
Publisher excerpt: Isomorphic Labs Ltd., an Alphabet Inc. spinoff working to accelerate drug discovery, is said to be raising a new funding round. The Bloomberg report that revealed the discussions today didn’t specify the size of the deal. The paper’s sources did, however, divulge that Isomorphic is eyeing a…